LOGSX
Live Oak Health Sciences Fund
1W: -0.6%
1M: -4.6%
3M: +1.3%
YTD: +8.5%
1Y: +16.9%
3Y: +35.8%
5Y: +38.6%
$25.61
-0.06 (-0.23%)
Weekly Expected Move ±1.7%
$25
$25
$26
$26
$27
ETF-Level Metrics
AUM$53M
Holdings30
Top 10 Wt106.7%
Beta0.42
% Profitable86%
Coverage186%
Portfolio Valuation
P/E14.8
P/B4.5
P/S1.0
EV/EBITDA12.2
P/FCF17.0
PEG0.45
Profitability & Returns
Gross Margin24.6%
Net Margin6.5%
ROE30.5%
ROA9.8%
ROIC30.1%
Div Yield1.34%
Leverage & Liquidity
Debt/Equity0.73
Debt/Assets0.24
Net Debt/EBITDA0.8x
Interest Cov16.5x
Current Ratio1.09
Quick Ratio0.80
Growth (YoY)
Revenue+10.9%
Net Income+34.4%
EPS+37.0%
FCF+43.4%
EBITDA+37.0%
Rev CAGR 3Y+11.9%
Quality Scores
Piotroski F6.6
Altman Z8.62
IS Quality74.8
IS Overall70.2
IS Value53.8
Median P/E23.9
Sector Breakdown
4 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 53 | 184.0% | 23.5 |
| Other | 4 | 19.4% | — |
| Industrials | 2 | 9.8% | 6.6 |
| Technology | 1 | 1.3% | 44.0 |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 60 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Mount Vernon Liquid Assets Portfolio, LLC Private | — | 10.93% | $5.7M | 5,747,803 | — | — | — |
| 2 | UNITED THERAPEUTICS CORP | UTHR | 6.40% | $3.2M | 5,543 | 17.9 | $23.0B | Healthcare |
| 3 | Cardinal Health, Inc. | 0HTG.L | 5.84% | $3.1M | 14,297 | 31.4 | $53.8B | Healthcare |
| 4 | CARDINAL HEALTH INC | 0HTG.L | 5.57% | $2.8M | 14,297 | 31.4 | $53.8B | Healthcare |
| 5 | Cencora Inc | ABC | 5.49% | $2.9M | 8,034 | 13.3 | $36.1B | Healthcare |
| 6 | JAZZ PHARMACEUTICALS PLC | JAZZ | 5.25% | $2.6M | 12,812 | 15.5 | $14.8B | Healthcare |
| 7 | NOVARTIS AG | NVS.JO | 5.01% | $2.5M | 16,784 | 6.6 | $1.8B | Industrials |
| 8 | CENCORA INC | ABC | 5.00% | $2.5M | 8,034 | 13.3 | $36.1B | Healthcare |
| 9 | AMGEN INC | 4332.HK | 4.95% | $2.5M | 7,077 | — | $998.5B | Healthcare |
| 10 | United Therapeutics Corporation | UTHR | 4.95% | $2.6M | 5,543 | 17.9 | $23.0B | Healthcare |
| 11 | Mount Vernon Liquid Assets Portfolio, LLC Private | — | 4.90% | $2.4M | 2,425,936 | — | — | — |
| 12 | MCKESSON CORP | 0JZU.L | 4.89% | $2.4M | 2,973 | 24.0 | $110.2B | Healthcare |
| 13 | Novartis AG | NVS.JO | 4.74% | $2.5M | 16,784 | 6.6 | $1.8B | Industrials |
| 14 | EXELIXIS INC | EX9.DE | 4.71% | $2.3M | 52,445 | 17.7 | $9.2B | Healthcare |
| 15 | Mckesson Corp. | 0JZU.L | 4.70% | $2.5M | 2,973 | 24.0 | $110.2B | Healthcare |
| 16 | REGENERON PHARMACEUTICALS INC | 0R2M.L | 4.66% | $2.3M | 3,260 | 17.6 | $79.6B | Healthcare |
| 17 | Amgen Inc. | 4332.HK | 4.60% | $2.4M | 7,077 | — | $998.5B | Healthcare |
| 18 | Regeneron Pharmaceuticals, Inc. | 0R2M.L | 4.59% | $2.4M | 3,260 | 17.6 | $79.6B | Healthcare |
| 19 | LANTHEUS HOLDINGS INC | LNTH | 4.50% | $2.2M | 26,355 | 23.7 | $6.5B | Healthcare |
| 20 | Exelixis, Inc. | EX9.DE | 4.12% | $2.2M | 52,445 | 17.7 | $9.2B | Healthcare |
| 21 | Jazz Pharmaceuticals PLC | JAZZ | 4.01% | $2.1M | 12,812 | 15.5 | $14.8B | Healthcare |
| 22 | Medpace Holdings Inc. | MEDP | 3.98% | $2.1M | 3,593 | 34.5 | $16.7B | Healthcare |
| 23 | JOHNSON & JOHNSON | JNJ.SW | 3.83% | $1.9M | 8,261 | 29.6 | $535.1B | Healthcare |
| 24 | BRISTOL-MYERS SQUIBB COMPANY | BMY.SW | 3.67% | $1.8M | 30,000 | 13.5 | $87.7B | Healthcare |
| 25 | Thermo Fisher Scientific Inc | TN8.DE | 3.66% | $1.9M | 3,329 | 35.2 | $214.6B | Healthcare |
| 26 | Gilead Sciences Inc. | GILD.SW | 3.61% | $1.9M | 13,391 | -55.7 | $143.2B | Healthcare |
| 27 | Johnson & Johnson | JNJ.SW | 3.57% | $1.9M | 8,261 | 29.6 | $535.1B | Healthcare |
| 28 | CIGNA GROUP (THE) | CGN.DE | 3.55% | $1.8M | 6,051 | 11.2 | $63.4B | Healthcare |
| 29 | GILEAD SCIENCES INC | GILD.SW | 3.54% | $1.8M | 13,391 | -55.7 | $143.2B | Healthcare |
| 30 | Vertex Pharmaceuticals Incorporated | VX1.DE | 3.42% | $1.8M | 3,831 | 29.1 | $113.3B | Healthcare |
| 31 | Intuitive Surgical Inc. | 0R29.L | 3.37% | $1.8M | 3,517 | 44.3 | $140.2B | Healthcare |
| 32 | NATIONAL HEALTHCARE CORP | NHC | 3.36% | $1.7M | 9,612 | 25.2 | $3.6B | Healthcare |
| 33 | Lantheus Holdings Inc | LNTH | 3.35% | $1.8M | 26,355 | 23.7 | $6.5B | Healthcare |
| 34 | VERTEX PHARMACEUTICALS INC | VX1.DE | 3.31% | $1.6M | 3,831 | 29.1 | $113.3B | Healthcare |
| 35 | INTUITIVE SURGICAL INC | 0R29.L | 3.25% | $1.6M | 3,517 | 44.3 | $140.2B | Healthcare |
| 36 | N/A Private | — | 3.18% | $1.6M | 1,575,546 | — | — | — |
| 37 | The Cigna Group | CGN.DE | 3.15% | $1.7M | 6,051 | 11.2 | $63.4B | Healthcare |
| 38 | MEDPACE HOLDINGS INC | MEDP | 3.04% | $1.5M | 3,593 | 34.5 | $16.7B | Healthcare |
| 39 | MERCK & COMPANY INC | 6MK.DE | 3.01% | $1.5M | 13,629 | 114.5 | $314.9B | Healthcare |
| 40 | INCYTE CORP | 0J9P.L | 2.98% | $1.5M | 15,511 | 14.2 | $22.8B | Healthcare |
| 41 | Incyte Corporation. | 0J9P.L | 2.95% | $1.6M | 15,511 | 14.2 | $22.8B | Healthcare |
| 42 | Merck & Co., Inc | 6MK.DE | 2.86% | $1.5M | 13,629 | 114.5 | $314.9B | Healthcare |
| 43 | IQVIA Holdings Inc. | 0JDM.L | 2.80% | $1.5M | 6,398 | 31.8 | $43.5B | Healthcare |
| 44 | National Healthcare Corporation | NHC | 2.61% | $1.4M | 9,612 | 25.2 | $3.6B | Healthcare |
| 45 | Elevance Health Inc. | ANTM | 2.52% | $1.3M | 3,831 | 2.1 | $114.6B | Healthcare |
| 46 | Medtronic PLC | 2M6.DE | 2.42% | $1.3M | 12,359 | 21.1 | $98.6B | Healthcare |
| 47 | Stryker Corporation | 0R2S.L | 2.39% | $1.3M | 3,396 | 28.3 | $103.0B | Healthcare |
| 48 | Novo Nordisk A/S | NVO | 2.25% | $1.2M | 19,907 | 9.5 | $165.7B | Healthcare |
| 49 | STRYKER CORP | 0R2S.L | 2.16% | $1.1M | 3,396 | 28.3 | $103.0B | Healthcare |
| 50 | LABCORP HOLDINGS INC | 0JSY.L | 2.15% | $1.1M | 4,153 | 25.3 | $25.2B | Healthcare |